TNFα and IFNγ but Not Perforin Are Critical for CD8 T Cell-Mediated Protection against Pulmonary Yersinia pestis Infection

A Protective Epitope in Type III Effector YopE Is a Major CD8 T Cell Antigen during Primary Infection with Yersinia pseudotuberculosis

(2011) Yue Zhang et al.   INFECTION AND IMMUNITY

Yersinia pestis YopE Contains a Dominant CD8 T Cell Epitope that Confers Protection in a Mouse Model of Pneumonic Plague

(2011) J.-S. Lin et al.   JOURNAL OF IMMUNOLOGY

Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines

(2011) Lauriane E. Quenee et al.   VACCINE

Community acquired bacterial pneumonia

(2010) Stavros Anevlavis et al.   EXPERT OPINION ON PHARMACOTHERAPY

IL-17 Contributes to Cell-Mediated Defense against Pulmonary Yersinia pestis Infection

(2010) J.-S. Lin et al.   JOURNAL OF IMMUNOLOGY

Hospital-Acquired Infections Due to Gram-Negative Bacteria

(2010) Anton Y. Peleg et al.   NEW ENGLAND JOURNAL OF MEDICINE

TNFα and IFNγ contribute to F1/LcrV-targeted immune defense in mouse models of fully virulent pneumonic plague

(2010) Jr-Shiuan Lin et al.   VACCINE

Absence of Inflammation and Pneumonia during Infection with Nonpigmented Yersinia pestis Reveals a New Role for the pgm Locus in Pathogenesis

(2009) H. Lee-Lewis et al.   INFECTION AND IMMUNITY

D27-pLpxL, an Avirulent Strain of Yersinia pestis, Primes T Cells That Protect against Pneumonic Plague

(2009) F. M. Szaba et al.   INFECTION AND IMMUNITY

CD8+ T Cells Restrict Yersinia pseudotuberculosis Infection: Bypass of Anti-Phagocytosis by Targeting Antigen-Presenting Cells

(2009) Molly A. Bergman et al.   PLoS Pathogens

Current challenges in the development of vaccines for pneumonic plague

(2008) Stephen T Smiley   Expert Review of Vaccines

Antibodies and cytokines independently protect against pneumonic plague

(2008) Lawrence W. Kummer et al.   VACCINE